KRAS and neoplasm: For KRAS codons 12 and 13 mutations in 29 metastatic CRCs, 83.3% sensitivity, 86.9% specificity and 86.2% accuracy (Table 2A) were revealed between cfDNA and direct DNA sequencing of tumor FFPE specimens.